Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-5.13	-5198.36	-4944.63
Graham Fair Price	0.00	1.15	1.15
PEG	inf	0.00	0.80
Price/Book	5.57	0.67	0.63
Price/Cash Flow	-5.57	-512.71	-485.68
Prices/Earnings	-5.57	-54.99	-52.10
Price/Sales	5.57	811.33	768.55
Price/FCF	-5.57	-512.71	-485.68
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	0.00	-3.06	-3.06
ROA	0.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	0.00
ROIC	< 0.005	< 0.005	3.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	3.62	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.68	0.00	inf
EPS QOQ	0.65	0.00	inf
FCF QOQ	-0.11	0.00	inf
Revenue QOQ	1.18	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	94.50	94.50	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.06	0.10	57.88
Quick Ratio	0.30	0.30	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	4.41	4.41	0.00
Cash	0.06	0.06	0.00
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	0.00
Revenue	< 0.005	< 0.005	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.30	0.30	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-385.70	-385.70	0.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating